Shattuck Labs to present SL-846 bispecific antibody data at UEG Week 2026
STTK•Shattuck Labs plans to present two scientific posters at UEG Week 2026 in Barcelona, scheduled for Oct. 17-20. One will cover preclinical work on its SL-846 program, and the other will examine immune-complex effects that could drive anti-drug antibodies.
1. Two posters planned
Shattuck Labs flagged two posters for UEG Week 2026, with data not yet presented. One poster on preclinical work supporting the SL-846 bispecific antibody program, which is aimed at inflammatory disease, is slated for a moderated session on Oct. 19. The second evaluates immune-complex effects that could drive anti-drug antibodies and raise potential treatment-compatibility concerns in inflammatory bowel disease.
